Digital MarketingService
Pharmaceutical marketing, B2B only
Marketing to trade and professional audiences, within advertising restrictions that vary by market.
Kaelo Global is a Dubai company licensed in Meydan Free Zone, with over 100 clients served so far.
At a glance
What it is
Medical review belongs inside the production schedule, from the very start.
A principal, Kaelo Global digital marketing
Pharmaceutical marketing, as we practise it, means business-to-business communication with distributors, pharmacies, procurement teams and healthcare professionals, within the advertising restrictions that apply in each market. Promoting prescription medicines directly to consumers is prohibited in the markets we work in, and we do not attempt it. What remains is trade communication with unusually strict compliance requirements.
Good pharma B2B marketing builds medical, legal and regulatory review into the schedule from the first day. We map what can be said, to whom and in which market, agree the review steps with your team, and plan the work so that approvals are part of the timeline instead of a delay at the end.
Much of what pharmaceutical and healthcare distribution companies need is corporate, supply and distribution communication. That work matters to buyers and partners, it usually carries a lighter compliance burden than product promotion, and it draws on our experience in logistics and trade.
What's included
Six areas of scopeTrade and professional channels
Professional networks, specialist medical publishers and trade press allow targeting that consumer platforms restrict, each with its own compliance requirements.
Mapping restrictions by market
What may be said, and to whom, differs a great deal between markets. A campaign that complies in one country does not automatically comply in the next.
Review built into the workflow
Medical, legal and regulatory review is part of the production schedule instead of a checkpoint at the end. Leaving it until the end is a common reason pharmaceutical campaigns run late.
Corporate and distribution communications
Much of what pharmaceutical companies need is communication about supply, distribution and the business itself, which carries a lighter compliance burden than product promotion.
Distributor and pharmacy communications
Clear material for distributors, wholesalers and pharmacy buyers about availability, ordering, cold chain handling and service standards, reviewed by your own teams.
Trade exhibitions and events
Planning and material for trade exhibitions and professional events in the region, prepared well ahead so that review can be completed in time.
How the work runs
Scope and restriction map
The markets, the audiences and what is permitted in each, agreed in writing at the start.
The review path
Medical, legal and regulatory review built into the schedule from the start, with clear owners and realistic turnaround times agreed with your team.
Trade channels
Campaigns placed where the professional audience actually spends time, such as specialist publications, professional networks and industry events.
Reporting
Regular reports on reach within the professional audience, enquiries from trade buyers and the progress of each item through review.
When to come to us
- 01You are communicating with trade, professional or procurement audiences.
- 02You need corporate or distribution communications instead of product promotion.
- 03You have a review function we can plan the schedule around.
- 04You are entering a new Gulf market and need to understand what your communications can say there.
What we do not do
- Promoting prescription medicines directly to consumers. It is prohibited in our markets, and we will decline the brief.
- Any clinical, efficacy or safety claim. Those come from your medical team.
- Running creative that has not completed your own review process.
Related reading
Common questions
